IBB Among Technology ETFs
End-of-day Nov 17, 2026 · 39 Technology ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −4.7% | +1.4% | −4.6% | +22.7% | +26.3% | +80.4% | +34.8% | +143.9% | +696.0% |
| Peer average | −1.3% | −4.4% | −9.3% | −12.6% | +1.7% | +3.4% | +64.5% | +20.7% | +365.7% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$92 of every $1,000 in IBB is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 9.18% | $917.53 | 6.0M | $1.01B |
| 2 | AMGNAmgen | Healthcare | 8.62% | $861.70 | 2.1M | $948.7M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 7.91% | $791.34 | 1.6M | $871.2M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 6.69% | $669.25 | 774K | $736.8M |
| 5 | MRNAModerna | Healthcare | 5.58% | $557.56 | 2.9M | $613.9M |
| 6 | ARGXArgenx SE | Healthcare | 3.75% | $374.62 | 434K | $412.4M |
| 7 | NTRANatera | Healthcare | 2.75% | $275.38 | 1.1M | $303.2M |
| 8 | BIIBBiogen | Healthcare | 2.62% | $261.66 | 1.1M | $288.1M |
| 9 | ONCBeone Medicines AG | Healthcare | 2.45% | $245.28 | 657K | $270.1M |
| 10 | RVMDRevolution Medicines | Healthcare | 2.28% | $228.08 | 1.5M | $251.1M |
| 11 | ILMNIllumina | Healthcare | 2.11% | $211.42 | 1.2M | $232.8M |
| 12 | GMABGenmab Sponsored | Healthcare | 2.03% | $202.52 | 4.3M | $223.0M |
| 13 | INSMInsmed | Healthcare | 1.87% | $187.42 | 1.7M | $206.3M |
| 14 | UTHRUnited Therapeutics | Healthcare | 1.73% | $172.80 | 324K | $190.2M |
| 15 | INCYIncyte | Healthcare | 1.71% | $171.28 | 1.6M | $188.6M |
of the $347B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 9.18% |
| 2 | AMGN | Amgen | 8.62% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.91% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.69% |
| 5 | MRNA | Moderna | 5.58% |
| 6 | ARGX | Argenx SE | 3.75% |
| 7 | NTRA | Natera | 2.75% |
| 8 | BIIB | Biogen | 2.62% |
| 9 | ONC | Beone Medicines AG | 2.45% |
| 10 | RVMD | Revolution Medicines | 2.28% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.0112 |
| Jun 15, 2026 | Jun 18, 2026 | $0.0238 |
| Mar 17, 2026 | Mar 20, 2026 | $0.12 |
| Dec 16, 2025 | Dec 19, 2025 | $0.18 |
| Sep 16, 2025 | Sep 19, 2025 | $0.0828 |
| Mar 18, 2025 | Mar 21, 2025 | $0.12 |
| Dec 17, 2024 | Dec 20, 2024 | $0.0624 |
| Sep 25, 2024 | Sep 30, 2024 | $0.20 |
| Mar 21, 2024 | Mar 27, 2024 | $0.13 |
| Dec 20, 2023 | Dec 27, 2023 | $0.12 |
| Sep 26, 2023 | Oct 2, 2023 | $0.15 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0062 |